Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1980;4(3):183-7.
doi: 10.1007/BF00254016.

A sensitive radioimmunoassay for vincristine and vinblastine

A sensitive radioimmunoassay for vincristine and vinblastine

V S Sethi et al. Cancer Chemother Pharmacol. 1980.

Abstract

A rapid, sensitive and highly reproducible radioimmunoassay (RIA) has been devised for vincristine and vinblastine. These alkaloids bind to the antiserum very tightly with an association constant (Ka) of 5 x 10(9) M-1 as determined by Scatchard analysis. The kinetic association constant of the alkaloids, as determined by the 'on' and 'off' rates at 4 degrees C, is 30-fold higher than the Scatchard analysis value. At 4 degrees C, 80% of the alkaloid is bound to the antiserum within 20 min, and the remaining 20% reaches an equilibrium within 48-72 h. In the RIA procedure the amount of the alkaloid (1-2 ng) needed to compete for 50% binding remains unchanged when the reaction mixtures are incubated for 2, 4, or 20 h. By a modification of the RIA procedure, where the antiserum is first allowed to react with the unlabeled alkaloid followed by addition of the radiolabeled alkaloid, sensitivity of the assay has been increased five- to tenfold. Other drugs, such as adriamycin, CCNU, methyl CCNU, cyclophosphamide, 5-fluorouracil, heparin, hydrocortisone, prednisone, and nitrogen mustard do not interfere with the assay. This assay can thus be used to determine vincristine or vinblastine levels in 5 x 10(-10)--10(-9) M concentrations in biological fluids.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Cancer Res. 1977 Aug;37(8 Pt 1):2603-7 - PubMed
    1. Clin Pharmacol Ther. 1978 Jul;24(1):101-7 - PubMed
    1. Clin Pharmacol Ther. 1977 Oct;22(4):430-5 - PubMed
    1. Cancer Res. 1976 Oct;36(10):3684-9 - PubMed
    1. Cancer Res. 1975 Apr;35(4):975-80 - PubMed

Publication types